Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Multiple sclerosis in 2015: Managing the complexity of multiple sclerosis.
Neuronal activity regulates remyelination via glutamate signalling to oligodendrocyte progenitors.
Gatekeeper role of brain antigen-presenting CD11c+ cells in neuroinflammation.
Analysis of polymorphisms in RIG-I-like receptor genes in German multiple sclerosis patients.
Further validation of the Multiple Sclerosis Self-Efficacy Scale.
The best clinical paper on multiple sclerosis in 2014: Herodotus and Chataway - Commentary.
Passive Experimental Autoimmune Encephalomyelitis in C57BL/6 with MOG: Evidence of Involvement of B Cells.
Correction: Optic Nerve Magnetisation Transfer Ratio after Acute Optic Neuritis Predicts Axonal and Visual Outcomes.
Mimics and rare presentations of pediatric demyelination.
New extension study data with Novartis drug Gilenya® shows patients successfully treated for up to 7 years in relapsing MS
MRI measures should be a primary outcome endpoint in phase III randomized controlled trials in multiple sclerosis: No.
Paraneoplastic neuromyelitis optica spectrum disorder associated with metastatic carcinoid expressing aquaporin-4.
Few patients with neurodegenerative disorders require spinal surgery.
Modulation of subventricular zone oligodendrogenesis: a role for hemopressin?
Cognitive deficits in pediatric-onset multiple sclerosis: what does the future hold?
T Cell Activation Regulates CD6 Alternative Splicing by Transcription Dynamics and SRSF1.
N-Cadherin Promotes Recruitment and Migration of Neural Progenitor Cells from the SVZ Neural Stem Cell Niche into Demyelinated Lesions.
Neuropsychological features in childhood and juvenile multiple sclerosis: Five-year follow-up.
Disease modification in multiple sclerosis: an update.
[Cognitive deficits and dementia in patients with multiple sclerosis: status quo and open questions].
Comparison of LC-UV and LC-MS methods for simultaneous determination of teriflunomide, dimethyl fumarate and fampridine in human plasma, application to rat PK study.
Demyelination and Neurodegeneration in Multiple Sclerosis: The Role of Hypoxia.
Small-molecule Klotho enhancers as novel treatment of neurodegeneration.
Cell-specific effects in different immune subsets associated with SOCS1 genotypes in multiple sclerosis.
Metabolic dysfunctions in multiple sclerosis: implications as to causation, early detection, and treatment, a case control study.
Pages
« first
‹ previous
…
343
344
345
346
347
348
349
350
351
…
next ›
last »